Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - SEELOS THERAPEUTICS, INC. | Financial_Report.xls |
| 10-Q - FORM 10-Q - SEELOS THERAPEUTICS, INC. | v230961_10q.htm |
| EX-32.1 - EXHIBIT 32.1 - SEELOS THERAPEUTICS, INC. | v230961_ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - SEELOS THERAPEUTICS, INC. | v230961_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - SEELOS THERAPEUTICS, INC. | v230961_ex31-2.htm |
| EX-10.3 - EXHIBIT 10.3 - SEELOS THERAPEUTICS, INC. | v230961_ex10-3.htm |
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Steve Martin, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Apricus Biosciences, Inc. on Form 10-Q for the quarter ended June 30, 2011, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Apricus Biosciences, Inc.
|
Date: August 15, 2011
|
By:
|
|
||||
|
/S/ STEVE MARTIN
|
||||||
|
Name
Title:
|
Steve Martin
Chief Financial Officer
|
|||||
36